《非小细胞肺癌肺段切除术亚洲专家共识:改良Delphi研究》解读

Interpretation of Asia expert consensus on segmentectomy in non-small cell lung cancer:A modified Delphi study

随着肺癌发病率的逐年升高,肺段切除术作为经选择的早期非小细胞肺癌患者手术治疗的一种选择,越来越受到广大胸外科专家的青睐。但目前仍然缺乏关于肺段切除的具体指南。2023年4月,15名亚洲胸外科专家共同发布了《非小细胞肺癌肺段切除术亚洲专家共识:改良Delphi研究》,该共识在肺段切除术患者适应证、方法、淋巴结评估3个方面共提出了36项专家共识。本文旨在对该共识进行简要解读,以供广大同仁在临床实践中参考。

As the incidence of lung cancer continues to rise,segmentectomy has emerged as a favored surgical technique for treating selective early-stage non-small cell lung cancer patients,gaining increasing support from thoracic surgery specialists.However,there remains a deficiency in clinical guidance concerning indications and other related aspects for segmentectomy.In April 2023,a collaborative effort among 15 Asia thoracic surgery experts led to the publication of the"Asian expert consensus on segmentectomy in non-small cell lung cancer:A modified Delphi study".This study presents a total of 36 expert consensus agreements across three aspects:patient indications,surgical approaches,lymph node assessment,outlining key principles of them.This paper intends to provide a brief interpretation of these consensuses for the reference of colleagues in clinical practice.